日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bone morphogenetic protein 10, a rising star in the field of diabetes and cardiovascular disease

骨形态发生蛋白10,糖尿病和心血管疾病领域的一颗冉冉升起的新星

Wang, Xueyin; Sun, Helin; Yu, Haomiao; Du, Bingyu; Fan, Qi; Jia, Baoxue; Zhang, Zhongwen

Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategies

加快创新抗肿瘤药物进入首次人体试验的速度,并纳入关键的降低风险策略

Yuqi Wang,Quan Quan,Camille Gleason,Helin Yu,Lujia Peng,Yanshen Kang,Ling Jiang,Kailun Wu,Jie Pan,Moxiyele Bao,Qing Zhu,Meiqi Yi,Ming Fang,Yue Zheng,Ling Qiu,Bin Xu,Xiang Li,Jinfeng Song,Jiamu Sun,Zheng Zhang,Zijun Su,Jara Lin,Yuanyuan Xie,April Xu,Xiling Song,Chichi Huang,Zhirong Shen,Lai Wang,Jing Song

A simple new method for aged seed utilization based on melatonin-mediated germination and antioxidant nutrient production

一种基于褪黑素介导的萌发和抗氧化营养物质产生的陈旧种子利用新方法

Yu, Song; Zhu, Xuetian; Yang, Helin; Yu, Lihe; Zhang, Yifei

Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain

两种老药 NVP-AEW541 和 GSK-J4 被重新用于治疗弓形虫 RH 菌株

Shuxian Liu, Mimi Wu, Qianqian Hua, Daiqiang Lu, Yuan Tian, Helin Yu, Linyan Cheng, Yinqi Chen, Jiaxin Cao, Xin Hu, Feng Tan

Conjugation of DM1 to anti-CD30 antibody has potential antitumor activity in CD30-positive hematological malignancies with lower systemic toxicity

DM1与抗CD30抗体的偶联物对CD30阳性血液系统恶性肿瘤具有潜在的抗肿瘤活性,且全身毒性较低。

Yijun Shen,Tong Yang,Xuemei Cao,Yifan Zhang,Li Zhao,Hua Li,Teng Zhao,Jun Xu,Hengbin Zhang,Qingsong Guo,Junli Cai,Bei Gao,Helin Yu,Sicheng Yin,Ruiwen Song,Jingsong Wu,Lingyu Guan,Guanghao Wu,Li Jin,Yong Su,Yanjun Liu